Stay updated with breaking news from Gel Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Galderma announced today the availability of EPSOLAY (benzoyl peroxide) Cream, 5% in the U.S. following approval by the U.S. Food and Drug...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Sol-Gel Technologies (NASDAQ:SLGL – Get Rating) had its price target raised by analysts at HC Wainwright from $20.00 to $21.00 in a research note issued on Monday, The Fly reports. HC Wainwright’s price target would suggest a potential upside of 185.33% from the company’s current price. Several other equities research analysts also recently commented on […]
The FDA has approved Epsolay (benzoyl peroxide) cream for the treatment of inflammatory lesions of rosacea in adults.
Dyne Therapeutics (NASDAQ:DYN – Get Rating) and Sol-Gel Technologies (NASDAQ:SLGL – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Profitability This table compares Dyne Therapeutics and Sol-Gel Technologies’ […]